Tsutomu Iwasa
Ikoma, 6300293, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Correction: Initial activities and prospects of MIRAY1: a youth-driven, society-endorsed initiative to cultivate future breast cancer physicians.
Journal: Breast cancer (Tokyo, Japan)
Published: September 06, 2026
Initial activities and prospects of MIRAY1: a youth-driven, society-endorsed initiative to cultivate future breast cancer physicians.
Journal: Breast cancer (Tokyo, Japan)
Published: June 04, 2026
Abemaciclib rechallenge after progression on abemaciclib plus endocrine therapy in patients with hormone receptor-positive HER2-negative metastatic breast cancer: results from the phase II again study (WJOG14220B).
Journal: Breast cancer research and treatment
Published: March 30, 2026
Quality-of-life assessment in the randomized JBCRG-M06/EMERALD study of eribulin plus dual HER2 blockade in HER2-positive locally advanced or metastatic breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: March 30, 2026
BRCA1/2 Reversion Mutations in Japanese Patients with Metastatic Breast Cancer Progressing on Olaparib: OLIVE (WJOG15321B).
Journal: Breast cancer (Tokyo, Japan)
Published: February 24, 2026
Development of Second Primary Malignancies in Long-term Survivors of Unresectable Esophageal Cancer.
Development of Second Primary Malignancies in Long-term Survivors of Unresectable Esophageal Cancer.
Journal: Cancer diagnosis & prognosis
Published: December 29, 2025
Efficacy and safety of eribulin mesylate vs. docetaxel or paclitaxel, combined with trastuzumab and pertuzumab, as first-line treatment for HER2-positive locally advanced or metastatic breast cancer: updated subgroup analyses of JBCRG-M06/EMERALD.
Journal: Breast cancer research and treatment
Published: December 26, 2025
Sacituzumab govitecan in Japanese participants with HR+/HER2- metastatic breast cancer: primary results from the phase II ASCENT-J02 study.
Journal: Japanese journal of clinical oncology
Published: December 11, 2025
Olanzapine for nausea and vomiting in people with breast cancer treated with trastuzumab deruxtecan: plain language summary of the ERICA study.
Journal: Future oncology (London, England)
Published: October 24, 2025
Quality of life with palbociclib plus tamoxifen in hormone receptor-positive, HER2-negative advanced breast cancer: results from PATHWAY, an Asian international, double-blind, randomized phase 3 trial.
Journal: Breast cancer (Tokyo, Japan)
Published: September 16, 2025
Study protocol of an open-label prospective phase II study of Durvalumab plus Carboplatin and Etoposide in advanced large cell neuroendocrine carcinoma of the lung (LOGIK2401: NECTAR study).
Journal: Cancer treatment and research communications
Published: July 29, 2025
Clinical and molecular landscape of metastatic extramammary Paget's disease.
Journal: The oncologist
Published: May 06, 2025
Last Updated: 09/26/2026